January 17, 2024
Walgreens was hit with a potential class action filed in California federal court by a consumer who claimed the pharmacy retail giant is selling an over-the-counter analgesic, phenazopyradine hydrohloride, to treat urinary tract infections, even though the drug is "unsafe, ineffective, and unlawful to sell."